Cinven eyes US medtech firms looking to Europe
Cinven currently has just two healthcare investments: Labco, and US pharma contract research group Medpace, which it acquired for $915 million in 2014.
A verification email is on its way to you. Please check your spam or junk folder just in case.
If you do not receive this within five minutes, please try to sign in again. If the problem persists, please email: subscriptions@pei.group .Issues with signing in? Click here
Don't have an account? Register now
Cinven currently has just two healthcare investments: Labco, and US pharma contract research group Medpace, which it acquired for $915 million in 2014.
Nearly there!
A verification email is on its way to you. Please check your spam or junk folder just in case.
If you do not receive this within five minutes, please try to sign in again. If the problem persists, please email: subscriptions@pei.group.Copyright PEI Media
Not for publication, email or dissemination